Cancer Biology & Therapy Journal Citation Rate 2026

ISSN 1538-4047 eISSN 1555-8576 Taylor & Francis US

Q1 Quartile Open Access Top Tier

About Cancer Biology & Therapy
{# Self-contained "answer block": one dense, LLM-quotable paragraph stating every core fact with an explicit as-of year, server-rendered and unique per journal. This is the canonical fact statement — other sections add narrative, they do not restate these numbers. #}

Cancer Biology & Therapy (CBT) is a peer-reviewed academic journal covering Cancer Cells and Metastasis and Cancer, Hypoxia, and Metabolism, published by Taylor & Francis in US, catalogued under ISSN 1538-4047 (e-ISSN 1555-8576). As of 2026, it has a 2025 2-Year Citation Rate (OpenAlex) of 6.11 (Q1 quartile) — the average number of citations its recent articles received over a two-year window, computed from OpenAlex open citation data, not the Clarivate (JCR) Impact Factor. It is fully open access, with an Article Processing Charge (APC) of approximately $2970 USD.

Cancer Biology & Therapy Citation Rate 2026 — In Context

Cancer Biology & Therapy has a 2025 2-Year Citation Rate (OpenAlex) of 6.11, placing it in the Q1 quartile within the Cancer Cells and Metastasis research area. This is the average number of citations the journal's recent articles received over a two-year window, computed from OpenAlex open citation data — not the Clarivate (JCR) Journal Impact Factor.

As a fully open-access publication, Cancer Biology & Therapy makes all articles freely available to readers for an Article Processing Charge of approximately $2970 USD.

Researchers looking to publish in Cancer Biology & Therapy should review the journal's submission tips and verify the latest indexing status against Scopus, DOAJ, and Web of Science using our indexing tracker. To compare Cancer Biology & Therapy against similar journals in the field, use our journal comparison tool.

Submission Tips for Cancer Biology & Therapy
  • Budget $2970 for the Article Processing Charge. Check if your institution or funder covers OA fees.
  • This journal covers Cancer Cells and Metastasis, Cancer, Hypoxia, and Metabolism, Cancer-related Molecular Pathways. Ensure your manuscript aligns with these scope areas to avoid desk rejection.
How Cancer Biology & … Compares
Citation Rate vs Field Avg
+92%
Field avg: 3.19
APC vs Field Avg
-3%
Field avg: $3052

Compared against 15 journals in the same research areas.

ISSN (Print) 1538-4047
ISSN (Online) 1555-8576
Publisher Taylor & Francis
Country United States
APC / Cost $2970 USD
In-depth profile & metrics

Cancer Biology & Therapy is published by Taylor & Francis and based in United States. It publishes open access with an article-processing charge of USD 2970.

In our subject taxonomy, Cancer Biology & Therapy is classified under Cancer Cells and Metastasis, Cancer, Hypoxia, and Metabolism, Cancer-related Molecular Pathways and Cell death mechanisms and regulation.

Cancer Biology & Therapy is indexed in OpenAlex. OpenAlex tracking provides an open, citable record of its output even where commercial indexing is absent.

Its most recent citation rate stands at 6.106.

Research Areas
Links
Frequently Asked Questions about Cancer Biology & Therapy

Cancer Biology & Therapy does not hold a Clarivate (JCR) Impact Factor on JournalsHub. Its 2-year citation rate, computed from OpenAlex open citation data, is 6.106 — an open proxy for citation impact, not the licensed JCR Impact Factor.

Yes, Cancer Biology & Therapy is an open access journal.

The Article Processing Charge (APC) for Cancer Biology & Therapy is $2970 USD.

Cancer Biology & Therapy is published by Taylor & Francis.

Cancer Biology & Therapy shows strong legitimacy signals: it is indexed in DOAJ, OpenAlex. Indexing in recognised databases such as Scopus and DOAJ is a reliable indicator of a peer-reviewed, non-predatory journal, because predatory titles are typically excluded from them. Always confirm the journal's scope and editorial board fit your work before submitting.

The ISSN of Cancer Biology & Therapy is 1538-4047. Its electronic ISSN (eISSN) is 1555-8576.

Cancer Biology & Therapy sits in the Q1 quartile based on its latest impact factor of 6.11, ranked across all journals in our database.
Live Indexing Status
Updated April 2026

Track real-time indexing metrics to ensure this journal meets your academic requirements.

OpenAlex
Verified
DOAJ
Indexed OA
Predatory Check
Clean
Citation Rate
6.106
2-Year Citation Rate (OpenAlex) · 2025
Historical Trend
Initial data points only
Citation Rate by Year
Year Value Source
2025 6.106 2-Year Mean Citedness (OpenAlex)

Metrics are sourced from OpenAlex, DOAJ and Scopus and reflect the latest data we hold. The headline figure is a 2-year citation rate (OpenAlex), not a Clarivate Impact Factor. Always verify against the journal's official site before relying on it. See our Methodology or report a correction.

Compare Journals

Compare Cancer Biology & Therapy against similar publications in its field:

Related Journals in Your Field

Metadata

Last updated: Apr 24, 2026

Updated by: openalex_bulk

OpenAlex ID: S169029442

Get weekly updates for Cancer Cells and Metastasis journals

Free. Monday morning. New citation rates, CFPs, indexing alerts, predatory watch list. One-click unsubscribe.

Comparison Shortlist
0 journals
Est. APC Budget: $0
Compare Now
Compare 0 Open → Clear
Save your viewing history
You've browsed several journals this session. Sign in to track them in one place and get weekly impact-factor updates.
Save with Google